1887

Journal of Medical Microbiology logo

Volume 67, Issue 9

The endogenous antiseptic N-chlorotaurine irreversibly inactivates Chlamydia pneumoniae and Chlamydia trachomatis Free

Abstract

Purpose. The antimicrobial activity of N-chlorotaurine (NCT), an endogenous long-lived oxidant applied topically, was tested against Chlamydiae in vitro.

Methodology. Elementary bodies of Chlamydia pneumoniae strain CV-6 and Chlamydia trachomatis serovars A and D were incubated in 0.01, 0.1 and 1 % (w/v) NCT solution at pH 7.1 and 37 °C. After different incubation times, aliquots were removed and grown in cell culture. The number of inclusion forming units was quantified by immunofluorescence and real-time qPCR.

Results/Key findings. Chlamydia pneumoniae and Chlamydia trachomatis were inactivated by 1 and 0.1 % NCT within 1 min. Moreover, 0.025–0.1 % NCT significantly reduced the number of intracellularly growing C. pneumoniae within 30 min.

Conclusions. This is the first study demonstrating the antimicrobial activity of NCT against Chlamydiae. Clinical implications of these findings have to be investigated in further trials.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antiseptic , chlamydia , chloramines , N-chlorotaurine and oxidant
© 2018 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000815
2018-08-03
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/9/1410.html?itemId=/content/journal/jmm/10.1099/jmm.0.000815&mimeType=html&fmt=ahah

References

  1. Marcinkiewicz J, Kontny E. Taurine and inflammatory diseases. Amino Acids 2014; 46:7–20 [View Article][PubMed]
     [Google Scholar]
  2. Martini C, Hammerer-Lercher A, Zuck M, Jekle A, Debabov D et al. Antimicrobial and anticoagulant activities of N-chlorotaurine, N,N-dichloro-2,2-dimethyltaurine, and N-monochloro-2,2-dimethyltaurine in human blood. Antimicrob Agents Chemother 2012; 56:1979–1984 [View Article][PubMed]
     [Google Scholar]
  3. Gottardi W, Nagl M. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch Pharm 2002; 335:411–421 [View Article][PubMed]
     [Google Scholar]
  4. Gottardi W, Nagl M. N-chlorotaurine, a natural antiseptic with outstanding tolerability. J Antimicrob Chemother 2010; 65:399–409 [View Article][PubMed]
     [Google Scholar]
  5. Arnitz R, Stein M, Bauer P, Lanthaler B, Jamnig H et al. Tolerability of inhaled N-chlorotaurine in humans: a double-blind randomized phase I clinical study. Ther Adv Respir Dis 2018; 12:1–14 [View Article][PubMed]
     [Google Scholar]
  6. Geiger R, Treml B, Pinna A, Barnickel L, Prossliner H et al. Tolerability of inhaled N-chlorotaurine in the pig model. BMC Pulm Med 2009; 9:33 [View Article][PubMed]
     [Google Scholar]
  7. Nagl M, Eitzinger C, Dietrich H, Anliker M, Reinold S et al. Tolerability of inhaled N-chlorotaurine versus sodium chloride in the mouse. J Med Res Prac 2013; 2:163–170
     [Google Scholar]
  8. Schwienbacher M, Treml B, Pinna A, Geiger R, Reinstadler H et al. Tolerability of inhaled N-chlorotaurine in an acute pig streptococcal lower airway inflammation model. BMC Infect Dis 2011; 11:231 [View Article][PubMed]
     [Google Scholar]
  9. Stamm WE, Batteiger BE. Introduction to Chlamydia and Chlamydophila. In Mandell GL, Bennett JE, Dolin R. (editors) Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Philadelphia, PA: Churchill Livingstone Elsevier; 2010 pp. 2439–2442
     [Google Scholar]
  10. Kohlhoff SA, Hammerschlag MR. Treatment of Chlamydial infections: 2014 update. Expert Opin Pharmacother 2015; 16:205–212 [View Article][PubMed]
     [Google Scholar]
  11. Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol 2010; 5:1427–1442 [View Article][PubMed]
     [Google Scholar]
  12. Borel N, Leonard C, Slade J, Schoborg RV. Chlamydial antibiotic resistance and treatment failure in veterinary and human medicine. Curr Clin Microbiol Rep 2016; 3:10–18 [View Article][PubMed]
     [Google Scholar]
  13. Mestrovic T, Ljubin-Sternak S. Molecular mechanisms of Chlamydia trachomatis resistance to antimicrobial drugs. Front Biosci 2018; 23:656–670 [View Article][PubMed]
     [Google Scholar]
  14. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72:1843–1855 [View Article][PubMed]
     [Google Scholar]
  15. Romanowski EG, Yates KA, Teuchner B, Nagl M, Irschick EU et al. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model. Invest Ophthalmol Vis Sci 2006; 47:2021–2026 [View Article][PubMed]
     [Google Scholar]
  16. Teuchner B, Nagl M, Schidlbauer A, Ishiko H, Dragosits E et al. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis–a double-blind, randomized, phase-2 clinical trial. J Ocul Pharmacol Ther 2005; 21:157–165 [View Article][PubMed]
     [Google Scholar]
  17. Blasi F, Damato S, Cosentini R, Tarsia P, Raccanelli R et al. Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002; 57:672–676 [View Article][PubMed]
     [Google Scholar]
  18. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest 2007; 132:1962–1966 [View Article][PubMed]
     [Google Scholar]
  19. Plaunt MR, Hatch TP. Protein synthesis early in the developmental cycle of Chlamydia psittaci. Infect Immun 1988; 56:3021–3025[PubMed]
     [Google Scholar]
  20. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31:827–832[PubMed]
     [Google Scholar]
  21. Bellmann-Weiler R, Martinz V, Kurz K, Engl S, Feistritzer C et al. Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma. Immunobiology 2010; 215:842–848 [View Article][PubMed]
     [Google Scholar]
  22. Maass M, Dalhoff K. Transport and storage conditions for cultural recovery of Chlamydia pneumoniae. J Clin Microbiol 1995; 33:1793–1796[PubMed]
     [Google Scholar]
  23. Gottardi W, Nagl M. Active halogen compounds and proteinaceous material: loss of activity of topical anti-infectives by halogen consumption. J Pharm Pharmacol 2013; 65:213–218 [View Article][PubMed]
     [Google Scholar]
  24. Bellmann-Weiler R, Schroll A, Engl S, Nairz M, Talasz H et al. Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis. Immunobiology 2013; 218:969–978 [View Article][PubMed]
     [Google Scholar]
  25. Sostaric-Zuckermann IC, Borel N, Kaiser C, Grabarevic Z, Pospischil A. Chlamydia in canine or feline coronary arteriosclerotic lesions. BMC Res Notes 2011; 4:350 [View Article][PubMed]
     [Google Scholar]
  26. Gottardi W, Nagl M. Chlorine covers on living bacteria: the initial step in antimicrobial action of active chlorine compounds. J Antimicrob Chemother 2005; 55:475–482 [View Article][PubMed]
     [Google Scholar]
  27. Nagl M, Hengster P, Semenitz E, Gottardi W. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 1999; 43:805–809 [View Article][PubMed]
     [Google Scholar]
  28. Arnitz R, Sarg B, Ott HW, Neher A, Lindner H et al. Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics 2006; 6:865–869 [View Article][PubMed]
     [Google Scholar]
  29. Nagl M, Hess MW, Pfaller K, Hengster P, Gottardi W. Bactericidal activity of micromolar N-chlorotaurine: evidence for its antimicrobial function in the human defense system. Antimicrob Agents Chemother 2000; 44:2507–2513 [View Article][PubMed]
     [Google Scholar]
  30. Nagl M, Pfausler B, Schmutzhard E, Fille M, Gottardi W. Tolerance and bactericidal action of N-chlorotaurine in a urinary tract infection by an omniresistant Pseudomonas aeruginosa. Zentralblatt für Bakteriologie 1998; 288:217–223 [View Article]
     [Google Scholar]
  31. Gottardi W, Arnitz R, Nagl M. N-Chlorotaurine and ammonium chloride: an antiseptic preparation with strong bactericidal activity. Int J Pharm 2007; 335:32–40 [View Article][PubMed]
     [Google Scholar]
  32. Grisham MB, Jefferson MM, Melton DF, Thomas EL. Chlorination of endogenous amines by isolated neutrophils. J Biol Chem 1984; 259:10404–10413
     [Google Scholar]
  33. Gottardi W, Debabov D, Nagl M. N-chloramines, a promising class of well-tolerated topical anti-infectives. Antimicrob Agents Chemother 2013; 57:1107–1114 [View Article][PubMed]
     [Google Scholar]
  34. Gottardi W, Klotz S, Nagl M. Superior bactericidal activity of N-bromine compounds compared to their N-chlorine analogues can be reversed under protein load. J Appl Microbiol 2014; 116:1427–1437 [View Article][PubMed]
     [Google Scholar]
  35. Gruber M, Moser I, Nagl M, Lackner M. Bactericidal and fungicidal activity of N-Chlorotaurine is enhanced in cystic fibrosis sputum medium. Antimicrob Agents Chemother 2017; 61:e02527-16 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000815
Loading
The endogenous antiseptic N-chlorotaurine irreversibly inactivates Chlamydia pneumoniae and Chlamydia trachomatis
J. Med. Microbiol. 67, 1410 (2018); https://doi.org/10.1099/jmm.0.000815
/content/journal/jmm/10.1099/jmm.0.000815
/content/journal/jmm/10.1099/jmm.0.000815
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error